These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 29483979)
1. Micro - Focused Phototherapy Associated To Janus Kinase Inhibitor: A Promising Valid Therapeutic Option for Patients with Localized Vitiligo. Gianfaldoni S; Tchernev G; Wollina U; Roccia MG; Fioranelli M; Lotti J; Rovesti M; Satolli F; Valle Y; Goren A; Tirant M; Situm M; Kovacevic M; França K; Lotti T Open Access Maced J Med Sci; 2018 Jan; 6(1):46-48. PubMed ID: 29483979 [TBL] [Abstract][Full Text] [Related]
2. Successful Treatment of Vitiligo Vietnamese Patients with Vitilinex® Herbal Bio-Actives in Combination with Phototherapy. Van TN; Minh TT; Huu DL; Huu SN; Thanh TV; Huu ND; Cam VT; Huyen ML; Hau KT; Trong HN; Gandolfi M; Satolli F; Feliciani C; Tirant M; Vojvodic A; Lotti T Open Access Maced J Med Sci; 2019 Jan; 7(2):283-286. PubMed ID: 30745981 [TBL] [Abstract][Full Text] [Related]
3. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios. Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485 [TBL] [Abstract][Full Text] [Related]
4. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo. Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443 [No Abstract] [Full Text] [Related]
5. Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis. Phan K; Phan S; Shumack S; Gupta M J Dermatolog Treat; 2022 Feb; 33(1):173-177. PubMed ID: 32096671 [TBL] [Abstract][Full Text] [Related]
6. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure. Liu LY; Strassner JP; Refat MA; Harris JE; King BA J Am Acad Dermatol; 2017 Oct; 77(4):675-682.e1. PubMed ID: 28823882 [TBL] [Abstract][Full Text] [Related]
7. Targeted Broadband UVB Phototherapy forthe Treatment of Localized Vitiligo. Kim JE; Ahn HH; Kye YC Ann Dermatol; 2008 Sep; 20(3):107-12. PubMed ID: 27303172 [TBL] [Abstract][Full Text] [Related]
8. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis. Li R; Qiao M; Wang X; Zhao X; Sun Q Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of narrowband UVB treatment in pediatric vitiligo: a retrospective analysis of 26 cases. Yazici S; Günay B; Başkan EB; Aydoğan K; Saricaoğlu H; Tunali Ş Turk J Med Sci; 2017 Apr; 47(2):381-384. PubMed ID: 28425237 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real-world clinical practice. Song H; Hu Z; Zhang S; Yang L; Liu Y; Wang T Dermatol Ther; 2022 Nov; 35(11):e15821. PubMed ID: 36114601 [TBL] [Abstract][Full Text] [Related]
11. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy. Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369 [TBL] [Abstract][Full Text] [Related]
12. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study. Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006 [TBL] [Abstract][Full Text] [Related]
13. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study. Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309 [TBL] [Abstract][Full Text] [Related]
14. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas. Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036 [TBL] [Abstract][Full Text] [Related]
15. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients. Linthorst Homan MW; Spuls PI; Nieuweboer-Krobotova L; de Korte J; Sprangers MA; Bos JD; Wolkerstorfer A; van der Veen JP J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):690-5. PubMed ID: 21711467 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of using fractional CO Ghasemloo S; Gauthier Y; Ghalamkarpour F J Dermatolog Treat; 2019 Nov; 30(7):697-700. PubMed ID: 30592235 [No Abstract] [Full Text] [Related]
17. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area. Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388 [TBL] [Abstract][Full Text] [Related]
18. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial. Abdelghani R; Ahmed NA; Darwish HM J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191 [TBL] [Abstract][Full Text] [Related]
19. Narrow-band UV-B micro-phototherapy: a new treatment for vitiligo. Menchini G; Tsoureli-Nikita E; Hercogova J J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):171-7. PubMed ID: 12705746 [TBL] [Abstract][Full Text] [Related]
20. Excellent Repigmentation of Generalized Vitiligo with Oral Baricitinib Combined with NB-UVB Phototherapy. Li X; Sun Y; Du J; Wang F; Ding X Clin Cosmet Investig Dermatol; 2023; 16():635-638. PubMed ID: 36936753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]